Partnering with the most efficient and reliable investigative sites is critical to clinical trial success. However, with most studies experiencing delays during site selection, or activation, choosing the right sites is proving more difficult.

Rather than increasing over time, we see that patient enrollment rates are decreasing. According to Tufts Center for the Study of Drug Development, nearly two-thirds of sites fail to meet the patient enrollment requirements for a given clinical trial.*

If a poorly performing site is selected, you risk major issues later in the trial, which can cause further delays.

Join Veeva’s Ashley Davidson and Paragon’s Chris McSpiritt to hear how adopting the right technology can help you avoid these delays. Discussions will include how to use content, data, and workflow together to significantly optimize the selection and activation processes.

Ashley will address how providing shared visibility to sponsors, CROs, and site partners can improve transparency when it comes to site selection rationale as well as site performance and scoring. This, in turn, improves communication across all stakeholders regarding site performance and ultimately reduces the burden on sites allowing them to focus on the patients.

*Reference: http://csdd.tufts.edu/news/complete_story/rd_pr_apr_2011

Keywords:

Speakers

Ashley Davidson, Director Vault Study Startup, Veeva Systems

Ashley Davidson brings over 16 years of clinical research experience to her role as the strategy lead for Veeva Vault Study Startup. Her industry experience encompasses all phases of research and therapeutic areas, having specialized in study start-up, regulatory affairs, proposal, and contract management.

Prior to joining Veeva, Ashley spent over 12 years in executive management-level positions overseeing global study start-up groups of mid-sized and large CROs. She was the executive director of clinical development at Acorn Applications, a small start-up company launching a core cloud-based study start-up management solution. Prior to Acorn, Ashley was director of customer success at goBalto, Inc., a cloud-based study start-up and site activation technology company. Ashley holds a bachelor’s degree in English from The University of North Carolina at Chapel Hill.

Message Presenter

Chris McSpiritt, Clinical Practice Lead, Paragon Solutions

Chris McSpiritt is the Clinical Practice Lead for Paragon’s Life Sciences Research and Development team. Chris has over 10 years of pharmaceutical industry experience in R&D and has applied his business architecture, business process management, and analytical skills to help pharmaceutical companies improve the conduct of clinical trials for global life sciences companies. Chris holds a BA in Psychology from the University of Notre Dame. He is an active member of the Business Architecture Guild, Association of Business Process Management Professionals, Project Management Institute, and Drug Information Association.

Message Presenter

Who Should Attend?

Senior professionals working with clinical data/clinical documentation, including:

Trial Master File (TMF) Management
Clinical Records Management
Clinical Trial Management
Clinical Operations
Clinical Trials Associates (CTA’s) / Clinical Research Associates (CRA’s)
Site Management
Study / Study Start-up (SSU) Management

Xtalks Partner

Veeva

Veeva Systems Inc. is a leader in cloud based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 550 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.veeva.com.